Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy
Neurological impairments are frequently detected in children surviving cerebral malaria (CM), the most severe neurological complication of infection with Plasmodium falciparum. The pathophysiology and therapy of long lasting cognitive deficits in malaria patients after treatment of the parasitic disease is a critical area of investigation. In the present study we used several models of experimental malaria with differential features to investigate persistent cognitive damage after rescue treatment. Infection of C57BL/6 and Swiss (SW) mice with Plasmodium berghei ANKA (PbA) or a lethal strain of Plasmodium yoelii XL (PyXL), respectively, resulted in documented CM and sustained persistent cognitive damage detected by a battery of behavioral tests after cure of the acute parasitic disease with chloroquine therapy. Strikingly, cognitive impairment was still present 30 days after the initial infection. In contrast, BALB/c mice infected with PbA, C57BL6 infected with Plasmodium chabaudi chabaudi and SW infected with non lethal Plasmodium yoelii NXL (PyNXL) did not develop signs of CM, were cured of the acute parasitic infection by chloroquine, and showed no persistent cognitive impairment. Reactive oxygen species have been reported to mediate neurological injury in CM. Increased production of malondialdehyde (MDA) and conjugated dienes was detected in the brains of PbA-infected C57BL/6 mice with CM, indicating high oxidative stress. Treatment of PbA-infected C57BL/6 mice with additive antioxidants together with chloroquine at the first signs of CM prevented the development of persistent cognitive damage. These studies provide new insights into the natural history of cognitive dysfunction after rescue therapy for CM that may have clinical relevance, and may also be relevant to cerebral sequelae of sepsis and other disorders.
Vyšlo v časopise:
Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000963
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000963
Souhrn
Neurological impairments are frequently detected in children surviving cerebral malaria (CM), the most severe neurological complication of infection with Plasmodium falciparum. The pathophysiology and therapy of long lasting cognitive deficits in malaria patients after treatment of the parasitic disease is a critical area of investigation. In the present study we used several models of experimental malaria with differential features to investigate persistent cognitive damage after rescue treatment. Infection of C57BL/6 and Swiss (SW) mice with Plasmodium berghei ANKA (PbA) or a lethal strain of Plasmodium yoelii XL (PyXL), respectively, resulted in documented CM and sustained persistent cognitive damage detected by a battery of behavioral tests after cure of the acute parasitic disease with chloroquine therapy. Strikingly, cognitive impairment was still present 30 days after the initial infection. In contrast, BALB/c mice infected with PbA, C57BL6 infected with Plasmodium chabaudi chabaudi and SW infected with non lethal Plasmodium yoelii NXL (PyNXL) did not develop signs of CM, were cured of the acute parasitic infection by chloroquine, and showed no persistent cognitive impairment. Reactive oxygen species have been reported to mediate neurological injury in CM. Increased production of malondialdehyde (MDA) and conjugated dienes was detected in the brains of PbA-infected C57BL/6 mice with CM, indicating high oxidative stress. Treatment of PbA-infected C57BL/6 mice with additive antioxidants together with chloroquine at the first signs of CM prevented the development of persistent cognitive damage. These studies provide new insights into the natural history of cognitive dysfunction after rescue therapy for CM that may have clinical relevance, and may also be relevant to cerebral sequelae of sepsis and other disorders.
Zdroje
1. HuntNH
GolenserJ
Chan-LingT
ParekhS
RaeC
2006 Immunopathogenesis of cerebral malaria. Int J Parasitol 36 569 582
2. GolenserJ
McQuillanJ
HeeL
MitchellAJ
HuntNH
2006 Conventional and experimental treatment of cerebral malaria. Int J Parasitol 36 583 593
3. van HensbroekMB
PalmerA
JaffarS
SchneiderG
KwiatkowskiD
1997 Residual neurologic sequelae after childhood cerebral malaria. J Pediatr 131 125 129
4. BoivinMJ
BangiranaP
ByarugabaJ
OpokaRO
IdroR
2007 Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics 119 e360 366
5. CarterJA
LeesJA
GonaJK
MuriraG
RimbaK
2006 Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol 48 51 57
6. CarterJA
Mung'ala-OderaV
NevilleBG
MuriraG
MturiN
2005 Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry 76 476 481
7. DugbarteyAT
SpellacyFJ
DugbarteyMT
1998 Somatosensory discrimination deficits following pediatric cerebral malaria. Am J Trop Med Hyg 59 393 396
8. HoldingPA
StevensonJ
PeshuN
MarshK
1999 Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg 93 529 534
9. DesruisseauxMS
GulinelloM
SmithDN
LeeSC
TsujiM
2008 Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis 197 1621 1627
10. SchofieldL
GrauGE
2005 Immunological processes in malaria pathogenesis. Nat Rev Immunol 5 722 735
11. EngwerdaC
BelnoueE
GrunerAC
ReniaL
2005 Experimental models of cerebral malaria. Curr Top Microbiol Immunol 297 103 143
12. de KossodoS
GrauGE
1993 Profiles of cytokine production in relation with susceptibility to cerebral malaria. J Immunol 151 4811 4820
13. LiC
SeixasE
LanghorneJ
2001 Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med Microbiol Immunol 189 115 126
14. BeckerK
TilleyL
VennerstromJL
RobertsD
RogersonS
2004 Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 34 163 189
15. PinoP
VouldoukisI
DugasN
Hassani-LoppionG
DugasB
2003 Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes. Ann N Y Acad Sci 1010 582 586
16. WieseL
KurtzhalsJA
PenkowaM
2006 Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol 200 216 226
17. HopkinsRO
JacksonJC
2006 Long-term neurocognitive function after critical illness. Chest 130 869 878
18. PamplonaA
FerreiraA
BallaJ
JeneyV
BallaG
2007 Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13 703 710
19. LacknerP
BeerR
HeusslerV
GoebelG
RudzkiD
2006 Behavioural and histopathological alterations in mice with cerebral malaria. Neuropathol Appl Neurobiol 32 177 188
20. BarichelloT
MartinsMR
ReinkeA
FeierG
RitterC
2005 Cognitive impairment in sepsis survivors from cecal ligation and perforation. Crit Care Med 33 221 223; discussion 262–223
21. ShearHL
MarinoMW
WanidworanunC
BermanJW
NagelRL
1998 Correlation of increased expression of intercellular adhesion molecule-1, but not high levels of tumor necrosis factor-alpha, with lethality of Plasmodium yoelii 17XL, a rodent model of cerebral malaria. Am J Trop Med Hyg 59 852 858
22. BelnoueE
KayibandaM
VigarioAM
DescheminJC
van RooijenN
2002 On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol 169 6369 6375
23. RandallLM
AmanteFH
McSweeneyKA
ZhouY
StanleyAC
2008 Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities. Infect Immun 76 3312 3320
24. IzquierdoI
BarrosDM
Mello e SouzaT
de SouzaMM
IzquierdoLA
1998 Mechanisms for memory types differ. Nature 393 635 636
25. BermpohlD
HalleA
FreyerD
DagandE
BraunJS
2005 Bacterial programmed cell death of cerebral endothelial cells involves dual death pathways. J Clin Invest 115 1607 1615
26. HalliwellB
2006 Oxidative stress and neurodegeneration: where are we now? J Neurochem 97 1634 1658
27. TaoufiqZ
PinoP
DugasN
ContiM
TefitM
2006 Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress. Mol Biochem Parasitol 150 166 173
28. RosenthalPJ
2008 Artesunate for the treatment of severe falciparum malaria. N Engl J Med 358 1829 1836
29. MurphySC
BremanJG
2001 Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg 64 57 67
30. PenetMF
ViolaA
Confort-GounyS
Le FurY
DuhamelG
2005 Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci 25 7352 7358
31. GlicksteinM
BerlucchiG
2008 Classical disconnection studies of the corpus callosum. Cortex 44 914 927
32. JohnCC
BangiranaP
ByarugabaJ
OpokaRO
IdroR
2008 Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 122 e92 99
33. SanniLA
FuS
DeanRT
BloomfieldG
StockerR
1999 Are reactive oxygen species involved in the pathogenesis of murine cerebral malaria? J Infect Dis 179 217 222
34. NahrevanianH
DascombeMJ
2001 Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasite Immunol 23 491 501
35. CordeiroRS
Assreuy FilhoJ
FloresCA
CunhaFQ
MartinsMA
1984 Pulmonary edema in mice infected with Plasmodium berghei. Involvement of catecholamines. Experientia 40 301 302
36. SarfoBY
ArmahHB
IruneI
AdjeiAA
OlverCS
2005 Plasmodium yoelii 17XL infection up-regulates RANTES, CCR1, CCR3 and CCR5 expression, and induces ultrastructural changes in the cerebellum. Malar J 4 63
37. MartinsYC
CarvalhoLJ
Daniel-RibeiroCT
2009 Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models. Neuroimmunomodulation 16 134 145
38. BudsonAE
PriceBH
2005 Memory dysfunction. N Engl J Med 352 692 699
39. ViannaMR
AlonsoM
ViolaH
QuevedoJ
de ParisF
2000 Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. Learn Mem 7 333 340
40. JarrardLE
1995 What does the hippocampus really do? Behav Brain Res 71 1 10
41. SquireLR
Zola-MorganS
1991 The medial temporal lobe memory system. Science 253 1380 1386
42. HeidbrederCA
GroenewegenHJ
2003 The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci Biobehav Rev 27 555 579
43. MogensenJ
MoustgaardA
KhanU
WortweinG
NielsenKS
2005 Egocentric spatial orientation in a water maze by rats subjected to transection of the fimbria-fornix and/or ablation of the prefrontal cortex. Brain Res Bull 65 41 58
44. IzquierdoI
MedinaJH
1995 Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 63 19 32
45. IzquierdoI
MedinaJH
1997 Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain structures. Neurobiol Learn Mem 68 285 316
46. EnnaceurA
DelacourJ
1988 A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 31 47 59
47. RosaRM
FloresDG
AppeltHR
BragaAL
HenriquesJA
2003 Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice. Neurosci Lett 341 217 220
48. LaatuS
RevonsuoA
JaykkaH
PortinR
RinneJO
2003 Visual object recognition in early Alzheimer's disease: deficits in semantic processing. Acta Neurol Scand 108 82 89
49. FailleD
El-AssaadF
AlessiMC
FusaiT
CombesV
2009 Platelet-endothelial cell interactions in cerebral malaria: the end of a cordial understanding. Thromb Haemost 102 1093 1102
50. PotterSM
MitchellAJ
CowdenWB
SanniLA
DinauerM
2005 Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun 73 4941 4947
51. FavreN
RyffelB
RudinW
1999 The development of murine cerebral malaria does not require nitric oxide production. Parasitology 118 ( Pt 2) 135 138
52. MohantyS
PatelDK
PatiSS
MishraSK
2006 Adjuvant therapy in cerebral malaria. Indian J Med Res 124 245 260
53. HalliwellB
2007 Biochemistry of oxidative stress. Biochem Soc Trans 35 1147 1150
54. RitterC
AndradesME
ReinkeA
Menna-BarretoS
MoreiraJC
2004 Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit Care Med 32 342 349
55. BarichelloT
MachadoRA
ConstantinoL
ValvassoriSS
ReusGZ
2007 Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit Care Med 35 2186 2190
56. De FloraS
IzzottiA
D'AgostiniF
CesaroneCF
1991 Antioxidant activity and other mechanisms of thiols involved in chemoprevention of mutation and cancer. Am J Med 91 122S 130S
57. AruomaOI
HalliwellB
HoeyBM
ButlerJ
1989 The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6 593 597
58. HalliwellB
1987 Oxidants and human disease: some new concepts. FASEB J 1 358 364
59. HalliwellB
1989 Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic Biol Med 7 645 651
60. MuD
ChangYS
VexlerZS
FerrieroDM
2005 Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke. Exp Neurol 195 407 415
61. PrassK
RuscherK
KarschM
IsaevN
MegowD
2002 Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 22 520 525
62. TeixeiraLK
FonsecaBP
Vieira-de-AbreuA
BarbozaBA
RobbsBK
2005 IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation. J Immunol 175 5931 5939
63. RogersDC
FisherEM
BrownSD
PetersJ
HunterAJ
1997 Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 8 711 713
64. QuevedoJ
ViannaMR
RoeslerR
de-ParisF
IzquierdoI
1999 Two time windows of anisomycin-induced amnesia for inhibitory avoidance training in rats: protection from amnesia by pretraining but not pre-exposure to the task apparatus. Learn Mem 6 600 607
65. TuonL
ComimCM
PetronilhoF
BarichelloT
IzquierdoI
2008 Memory-enhancing treatments reverse the impairment of inhibitory avoidance retention in sepsis-surviving rats. Crit Care 12 R133
66. TuonL
ComimCM
PetronilhoF
BarichelloT
IzquierdoI
2008 Time-dependent behavioral recovery after sepsis in rats. Intensive Care Med 34 1724 1731
67. SchroderN
O'DellSJ
MarshallJF
2003 Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49 89 96
68. DraperHH
HadleyM
1990 Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186 421 431
69. PuhlH
WaegG
EsterbauerH
1994 Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 233 425 441
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 6
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requirement of NOX2 and Reactive Oxygen Species for Efficient RIG-I-Mediated Antiviral Response through Regulation of MAVS Expression
- Formation of Complexes at Plasmodesmata for Potyvirus Intercellular Movement Is Mediated by the Viral Protein P3N-PIPO
- Insight into the Mechanisms of Adenovirus Capsid Disassembly from Studies of Defensin Neutralization
- Two Novel Point Mutations in Clinical Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection